AIRLINK 73.53 Decreased By ▼ -2.17 (-2.87%)
BOP 4.67 Decreased By ▼ -0.05 (-1.06%)
CNERGY 4.01 Decreased By ▼ -0.09 (-2.2%)
DFML 36.09 Decreased By ▼ -3.33 (-8.45%)
DGKC 86.55 Decreased By ▼ -2.05 (-2.31%)
FCCL 21.98 Decreased By ▼ -0.62 (-2.74%)
FFBL 30.01 Decreased By ▼ -0.39 (-1.28%)
FFL 9.18 Decreased By ▼ -0.04 (-0.43%)
GGL 9.86 Decreased By ▼ -0.16 (-1.6%)
HASCOL 6.25 Increased By ▲ 0.20 (3.31%)
HBL 105.01 Decreased By ▼ -0.24 (-0.23%)
HUBC 137.45 Decreased By ▼ -0.79 (-0.57%)
HUMNL 10.75 No Change ▼ 0.00 (0%)
KEL 4.49 Decreased By ▼ -0.14 (-3.02%)
KOSM 3.99 Decreased By ▼ -0.25 (-5.9%)
MLCF 36.70 Decreased By ▼ -1.26 (-3.32%)
OGDC 119.40 Decreased By ▼ -2.00 (-1.65%)
PAEL 23.97 Decreased By ▼ -0.43 (-1.76%)
PIBTL 6.05 Decreased By ▼ -0.13 (-2.1%)
PPL 112.50 Increased By ▲ 0.15 (0.13%)
PRL 22.81 Decreased By ▼ -0.62 (-2.65%)
PTC 11.90 Decreased By ▼ -0.66 (-5.25%)
SEARL 58.40 Decreased By ▼ -0.30 (-0.51%)
SNGP 61.11 Decreased By ▼ -0.44 (-0.71%)
SSGC 9.65 Decreased By ▼ -0.19 (-1.93%)
TELE 7.55 Decreased By ▼ -0.27 (-3.45%)
TPLP 9.54 Decreased By ▼ -0.26 (-2.65%)
TRG 63.10 Decreased By ▼ -1.09 (-1.7%)
UNITY 26.80 No Change ▼ 0.00 (0%)
WTL 1.29 Decreased By ▼ -0.06 (-4.44%)
BR100 7,566 Decreased By -60.2 (-0.79%)
BR30 24,087 Decreased By -272.5 (-1.12%)
KSE100 72,589 Decreased By -663.1 (-0.91%)
KSE30 23,137 Decreased By -263.6 (-1.13%)

The Ministry of Health has nominated Ilyas Nainitalwala as member of the sub-committee for tariff rationalisation of pharmaceutical sector for the budget 2004-05.
The Experts Advisory Cells of Ministry of Industries and Production has constituted a sub-committee for tariff rationalisation of pharmaceutical sector for budget 2004-05.
The Director General Health is the convenor of the sub-committee. The objective of this exercise is to formulate practical and desirable proposals to address all aspects of federal taxation ie customs duties, central excise duty, sales tax and income tax in co-ordination with CBR, with the objective of making the local industry competitive both in the domestic and international markets, and discouraging the tendency of seeking tax and tariff preferences instead of finding solutions in productivity enhancement, validation and quality improvement.
The committee will also play an important role in finding solution for other cost elements such as energy cost etc.
Ilyas is already Senior vice chairman of FPCCI standing committee on pharmaceuticals.

Copyright Business Recorder, 2004

Comments

Comments are closed.